Co-Win Ventures is a Hong Kong-based private investment office and secondaries investor focused on private equity, venture capital and private credit opportunities across Asia and North America. It specializes in direct secondaries, LP interests, GP-led continuation funds, GP stakes, minority stakes, strategic co-investments and alternative credit, while also referencing pre-IPO and later-stage venture opportunities. The firm also backs early- and later-stage life sciences and biotechnology companies in the United States and China, including biotechnology, oncology and drug discovery sectors.